Rathbones Group PLC Has $60.86 Million Stake in Danaher Corporation (NYSE:DHR)

Key Points

• Rathbones Group PLC reduced its stake in Danaher Corporation by 7.1%, now holding 296,882 shares valued at approximately $60.86 million.
• Multiple hedge funds have increased their investments in Danaher, with notable increases such as MGO One Seven LLC's stake boosting by 485.7% in Q1.
• Danaher Corporation recently reported earnings of $1.80 per share, exceeding expectations and showing a year-over-year revenue increase of 3.4%.

Rathbones Group PLC decreased its holdings in shares of Danaher Corporation (NYSE:DHR - Free Report) by 7.1% in the 1st quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 296,882 shares of the conglomerate's stock after selling 22,620 shares during the quarter. Rathbones Group PLC's holdings in Danaher were worth $60,861,000 at the end of the most recent quarter.

Other hedge funds have also recently added to or reduced their stakes in the company. Bank Pictet & Cie Europe AG raised its holdings in Danaher by 22.8% in the 4th quarter. Bank Pictet & Cie Europe AG now owns 192,731 shares of the conglomerate's stock valued at $44,241,000 after acquiring an additional 35,730 shares in the last quarter. Martingale Asset Management L P raised its holdings in shares of Danaher by 14.4% in the 4th quarter. Martingale Asset Management L P now owns 1,507 shares of the conglomerate's stock worth $346,000 after buying an additional 190 shares in the last quarter. Sagespring Wealth Partners LLC acquired a new position in shares of Danaher in the 4th quarter worth approximately $913,000. SageView Advisory Group LLC raised its holdings in shares of Danaher by 78.0% in the 4th quarter. SageView Advisory Group LLC now owns 4,271 shares of the conglomerate's stock worth $980,000 after buying an additional 1,871 shares in the last quarter. Finally, Cohen & Steers Inc. raised its holdings in shares of Danaher by 5.4% in the 4th quarter. Cohen & Steers Inc. now owns 1,177 shares of the conglomerate's stock worth $270,000 after buying an additional 60 shares in the last quarter. Institutional investors own 79.05% of the company's stock.

Analyst Ratings Changes

A number of equities analysts have recently issued reports on DHR shares. UBS Group dropped their target price on Danaher from $240.00 to $225.00 and set a "buy" rating for the company in a report on Wednesday, July 23rd. Jefferies Financial Group decreased their price target on Danaher from $260.00 to $230.00 and set a "buy" rating on the stock in a research report on Tuesday, April 22nd. Guggenheim reiterated a "buy" rating and issued a $250.00 price objective on shares of Danaher in a research report on Wednesday, July 23rd. JPMorgan Chase & Co. reduced their price target on Danaher from $280.00 to $260.00 and set an "overweight" rating on the stock in a research report on Tuesday, April 22nd. Finally, Wall Street Zen raised Danaher from a "hold" rating to a "buy" rating in a research note on Friday, June 27th. Three investment analysts have rated the stock with a hold rating and eighteen have issued a buy rating to the stock. According to data from MarketBeat.com, the company presently has a consensus rating of "Moderate Buy" and an average price target of $247.61.

Danaher Stock Performance

Danaher stock traded up $0.62 during midday trading on Friday, reaching $210.84. 3,210,213 shares of the company's stock were exchanged, compared to its average volume of 4,658,279. Danaher Corporation has a 52 week low of $171.00 and a 52 week high of $279.90. The company has a debt-to-equity ratio of 0.32, a quick ratio of 1.22 and a current ratio of 1.62. The firm has a market cap of $150.97 billion, a price-to-earnings ratio of 44.86, a P/E/G ratio of 2.93 and a beta of 0.73. The stock's 50-day simple moving average is $199.94 and its 200 day simple moving average is $199.87.

Danaher (NYSE:DHR - Get Free Report) last issued its quarterly earnings data on Tuesday, July 22nd. The conglomerate reported $1.80 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.64 by $0.16. Danaher had a return on equity of 10.70% and a net margin of 14.21%. The company had revenue of $5.94 billion during the quarter, compared to analysts' expectations of $5.83 billion. During the same quarter in the previous year, the company posted $1.72 earnings per share. The business's revenue was up 3.4% on a year-over-year basis. On average, analysts expect that Danaher Corporation will post 7.63 earnings per share for the current fiscal year.

Danaher Company Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.